News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
858,090 Results
Type
Article (87240)
Company Profile (722)
Press Release (770101)
Multimedia
Podcasts (163)
Webinars (25)
Section
Business (232976)
Career Advice (4136)
Deals (39782)
Drug Delivery (133)
Drug Development (91205)
Employer Resources (201)
FDA (18247)
Job Trends (17387)
News (397204)
Policy (39898)
Tag
Academia (3003)
Academic (2)
Accelerated approval (17)
Adcomms (34)
Allergies (119)
Alliances (56979)
ALS (135)
Alzheimer's disease (1643)
Antibody-drug conjugate (ADC) (204)
Approvals (18240)
Artificial intelligence (453)
Autoimmune disease (48)
Automation (23)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (146)
Biotechnology (483)
Bladder cancer (118)
Brain cancer (46)
Breast cancer (435)
Cancer (3531)
Cardiovascular disease (308)
Career advice (3550)
Career pathing (36)
CAR-T (229)
CDC (48)
Cell therapy (627)
Cervical cancer (29)
Clinical research (74925)
Collaboration (1282)
Company closure (4)
Compensation (861)
Complete response letters (50)
COVID-19 (2941)
CRISPR (77)
C-suite (507)
Cystic fibrosis (130)
Data (3758)
Decentralized trials (2)
Denatured (58)
Depression (97)
Diabetes (420)
Diagnostics (7045)
Digital health (30)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (214)
Drug pricing (169)
Drug shortages (36)
Duchenne muscular dystrophy (183)
Earnings (98637)
Editorial (53)
Employer branding (25)
Employer resources (169)
Events (132415)
Executive appointments (956)
FDA (20476)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1132)
Gene editing (164)
Generative AI (44)
Gene therapy (495)
GLP-1 (994)
Government (5348)
Grass and pollen (7)
Guidances (333)
Healthcare (20934)
HIV (48)
Huntington's disease (33)
IgA nephropathy (52)
Immunology and inflammation (223)
Immuno-oncology (18)
Indications (46)
Infectious disease (3159)
Inflammatory bowel disease (179)
Inflation Reduction Act (13)
Influenza (87)
Intellectual property (160)
Interviews (814)
IPO (17922)
IRA (59)
Job creations (5196)
Job search strategy (2863)
Kidney cancer (15)
Labor market (69)
Layoffs (624)
Leadership (30)
Legal (10144)
Liver cancer (89)
Longevity (12)
Lung cancer (511)
Lymphoma (251)
Machine learning (22)
Management (65)
Manufacturing (564)
MASH (117)
Medical device (14827)
Medtech (14845)
Mergers & acquisitions (22675)
Metabolic disorders (1071)
Multiple sclerosis (117)
NASH (23)
Neurodegenerative disease (183)
Neuropsychiatric disorders (49)
Neuroscience (2534)
NextGen: Class of 2025 (7687)
Non-profit (5095)
Now hiring (54)
Obesity (537)
Opinion (303)
Ovarian cancer (114)
Pain (152)
Pancreatic cancer (146)
Parkinson's disease (214)
Partnered (27)
Patents (382)
Patient recruitment (269)
Peanut (57)
People (66061)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23097)
Phase II (32536)
Phase III (24486)
Pipeline (2446)
Policy (279)
Postmarket research (3554)
Preclinical (10431)
Press Release (72)
Prostate cancer (172)
Psychedelics (49)
Radiopharmaceuticals (281)
Rare diseases (598)
Real estate (7411)
Recruiting (76)
Regulatory (27686)
Reports (64)
Research institute (2676)
Resumes & cover letters (650)
Rett syndrome (12)
RNA editing (15)
RSV (64)
Schizophrenia (119)
Series A (186)
Series B (139)
Service/supplier (30)
Sickle cell disease (75)
Special edition (24)
Spinal muscular atrophy (168)
Sponsored (40)
Startups (4314)
State (2)
Stomach cancer (17)
Supply chain (94)
Tariffs (82)
The Weekly (103)
Vaccines (1010)
Venture capital (63)
Weight loss (372)
Women's health (56)
Worklife (21)
Date
Today (148)
Last 7 days (475)
Last 30 days (2418)
Last 365 days (33882)
2025 (23629)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (78)
Alaska (7)
Arizona (295)
Arkansas (14)
Asia (50795)
Australia (8923)
California (8901)
Canada (2699)
China (837)
Colorado (376)
Connecticut (395)
Delaware (239)
Europe (116652)
Florida (1311)
Georgia (303)
Hawaii (3)
Idaho (67)
Illinois (787)
India (45)
Indiana (429)
Iowa (19)
Japan (269)
Kansas (121)
Kentucky (35)
Louisiana (20)
Maine (75)
Maryland (1215)
Massachusetts (6709)
Michigan (295)
Minnesota (541)
Mississippi (4)
Missouri (113)
Montana (32)
Nebraska (26)
Nevada (102)
New Hampshire (76)
New Jersey (2453)
New Mexico (31)
New York (2422)
North Carolina (1360)
North Dakota (10)
Northern California (3952)
Ohio (281)
Oklahoma (18)
Oregon (49)
Pennsylvania (1854)
Puerto Rico (18)
Rhode Island (44)
South America (1655)
South Carolina (45)
South Dakota (1)
Southern California (3388)
Tennessee (142)
Texas (1391)
United States (33023)
Utah (265)
Virginia (238)
Washington D.C. (82)
Washington State (763)
West Virginia (4)
Wisconsin (91)
There are 858,090 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Lantern Pharma’s LP-184 Phase 1a Clinical Trial Achieves All Primary Endpoints with Robust Safety Profile and Promising Antitumor Activity in Multiple Advanced Solid Tumors
September 17, 2025
·
9 min read
Press Releases
Tandem Diabetes Care Announces Publication Showing Adults With Type 2 Diabetes Benefit from Automated Insulin Delivery Regardless of C-Peptide Levels
September 17, 2025
·
5 min read
Press Releases
Crossbow Therapeutics Doses First Patient in Phase 1 Trial of CBX-250 for Myeloid Malignancies
September 17, 2025
·
3 min read
Press Releases
Longevity Health Appoints Ben Lerer as Chief Executive Officer
September 17, 2025
·
2 min read
Press Releases
Meridian Bioscience Eliminates Cold Chain with the First Liquid Ambient Temperature Stable qPCR Master Mixes
September 17, 2025
·
4 min read
Press Releases
Enveric Biosciences Receives FDA Response and Streamlines Plans for EB-003 IND Submission
September 17, 2025
·
4 min read
Press Releases
ClostraBio Announces Key Milestones: Board Appointment of Industry Veteran Scott Ravech and Publication of CLB101™ Safety Data
September 17, 2025
·
2 min read
Press Releases
Prota Therapeutics Announces PRT120 Follow-on Study Awarded EAACI Prize for Long-Term Post-Treatment Data Demonstrating Durable Remission Following 18 months of PRT120 Peanut Oral Immunotherapy
September 17, 2025
·
6 min read
Press Releases
Virtual SOHO Breakthroughs in Blood Cancers meeting launches November 20, 2025
September 17, 2025
·
1 min read
Press Releases
Quetzal Therapeutics Appoints Dr. Shaad Abedin as Chief Medical Officer
September 17, 2025
·
2 min read
1 of 85,809
Next
